Please login to the form below

Not currently logged in
Email:
Password:

Sanpower Group

This page shows the latest Sanpower Group news and features for those working in and with pharma, biotech and healthcare.

Valeant uncouples Dendreon and skincare brands to cut debt

Valeant uncouples Dendreon and skincare brands to cut debt

Agrees deals worth $2.1bn with L’Oreal and Sanpower Group. Dendreon's Provenge cancer vaccine. ... cosmetics giant L'Oreal for $1.3bn and the Dendreon cancer vaccine business to China's Sanpower Group for around $820m.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    Bringing in an additional $819.9m in cash, Valeant also sold its equity interest in Dendreon (manufacturer of Provenge, a personalised immunotherapy) to the Sanpower Group. ... 960. Valeant. Sanpower Group. Divestment. Dendreon equity interest. 820.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics